Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients

Oncology Letters ◽

10.3892/ol_00000127 ◽

2010 ◽

Vol 1 (4) ◽

pp. 729-732 ◽

Author(s):

J. KÖLLERMANN ◽

H. ALBRECHT ◽

T. SCHLOMM ◽

H. HULAND ◽

M. GRAEFEN ◽

...

Keyword(s):

Prostate Cancer ◽

Gene Mutations ◽

Hormone Refractory Prostate Cancer ◽

Braf Gene ◽

Caucasian Patients ◽

Hormone Refractory

Download Full-text

Pattern of Somatic Androgen Receptor Gene Mutations in Patients with Hormone-Refractory Prostate Cancer

Laboratory Investigation ◽

10.1097/01.lab.0000038924.67707.75 ◽

2002 ◽

Vol 82 (11) ◽

pp. 1591-1598 ◽

Author(s):

Eija-R Hyytinen ◽

Kyllikki Haapala ◽

James Thompson ◽

Ilkka Lappalainen ◽

Mikko Roiha ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Gene ◽

Gene Mutations ◽

Androgen Receptor Gene ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Androgen receptor gene mutations in hormone-refractory prostate cancer

The Journal of Pathology ◽

10.1002/(sici)1096-9896(199912)189:4<559::aid-path471>3.0.co;2-y ◽

1999 ◽

Vol 189 (4) ◽

pp. 559-563 ◽

Author(s):

Mika J. Wall�n ◽

Marika Linja ◽

Kaius Kaartinen ◽

Johanna Schleutker ◽

Tapio Visakorpi

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Gene ◽

Gene Mutations ◽

Androgen Receptor Gene ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

718 POSTER The pharmacokinetic and tolerability profile of once-daily oral ZD4054 in Japanese and Caucasian patients with hormone-refractory prostate cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70517-7 ◽

2007 ◽

Vol 5 (4) ◽

pp. 112-113 ◽

Author(s):

M. Ranson ◽

M. Usami ◽

M. Maruoka ◽

A. Yamaguchi ◽

R.A. Cowan ◽

...

Keyword(s):

Prostate Cancer ◽

Tolerability Profile ◽

Hormone Refractory Prostate Cancer ◽

Caucasian Patients ◽

Hormone Refractory

Download Full-text

Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib

The Prostate ◽

10.1002/pros.20530 ◽

2007 ◽

Vol 67 (6) ◽

pp. 603-604 ◽

Author(s):

Giuseppe Curigliano ◽

Giuseppe Pelosi ◽

Tommaso De Pas ◽

Giuseppe Renne ◽

Ottavio De Cobelli ◽

...

Keyword(s):

Prostate Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Gene ◽

Growth Factor Receptor ◽

Gene Mutations ◽

Hormone Refractory Prostate Cancer ◽

Epidermal Growth ◽

Hormone Refractory

Download Full-text

147: Low Concentration of a Histone Deacetylase Inhibitor, Depsipeptide (FK228), Enhances the Effect of Gemcitabine and Docetaxel in Hormone Refractory Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)30412-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 50-51

Author(s):

Masatoshi Kanzaki ◽

Hideaki Kakinuma ◽

Teruaki Kumazawa ◽

Takamitsu Inoue ◽

Mitsuru Saito ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hormone Refractory Prostate Cancer ◽

Prostate Cancer Cells ◽

Low Concentration ◽

Deacetylase Inhibitor ◽

Hormone Refractory

Download Full-text

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)30844-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 202-202

Author(s):

Hirotsugu Uemura ◽

Motoyoshi Tanaka ◽

Shigeya Uejima ◽

Takafumi Minami ◽

Kiyohide Fujimoto ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

1014: Satraplatin Significantly Improves Progression Free Survival (PFS) and Pain Control in Patients with Advanced Hormone-Refractory Prostate Cancer (HRPC): Preliminary Results from the Phase III Sparc Trial

The Journal of Urology ◽

10.1016/s0022-5347(18)31242-4 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 335-335 ◽

Author(s):

Oliver Sartor ◽

Cora Sternberg ◽

J. Alfred Witjes ◽

Gurkamal Chatta ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Pain Control ◽

Progression Free Survival ◽

Phase Iii ◽

Hormone Refractory Prostate Cancer ◽

Free Survival ◽

Preliminary Results ◽

Hormone Refractory

Download Full-text

829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact?

The Journal of Urology ◽

10.1016/s0022-5347(18)34998-x ◽

2005 ◽

Vol 173 (4S) ◽

pp. 225-225

Author(s):

Peter Olbert ◽

Andres J. Schrader ◽

Axel Hegele ◽

Zoltan Varga ◽

Axel Heidenreich ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Impact ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

613: Sodium Selenate Inhibits the Progression of Hormone Refractory Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)37875-3 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 163-163

Author(s):

Niall M. Corcoran ◽

Anthony J. Costello

Keyword(s):

Prostate Cancer ◽

Sodium Selenate ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Development and Validation of LC-MS/MS Assays for GMC1, A Novel Hormone Refractory Prostate Cancer Molecule for Application to Pre-clinical Studies

10.26226/morressier.57d6b2b5d462b8028d88e627 ◽

2016 ◽

Author(s):

Oscar Ekpenyong

Keyword(s):

Prostate Cancer ◽

Clinical Studies ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Development And Validation

Download Full-text